Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth H Whitham

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Neurology and Neuroscience Reports|June 18, 2010
Multiple sclerosis and vitamin D: a review and recommendationsAndrew J Solomon, Ruth H Whitham
Neurology. Clinical Practice|April 23, 2016
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patientsDennis N Bourdette, Daniel M Hartung, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Sharia Ahmed, et al.
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Sharia Ahmed, et al.
Neurology|April 26, 2015
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?Daniel M Hartung, Dennis N Bourdette, Sharia M Ahmed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Synthetic Peptide dendrimers block the development and expression of experimental allergic encephalomyelitisKeith W Wegmann, Cynthia R Wagner, Ruth H Whitham, et al.
Journal of Neuroimmunology|July 7, 2014
Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitisKeith W Wegmann, H G Archie Bouwer, Ruth H Whitham, et al.
Journal of Neuroimmunology|April 25, 2013
Targeting T cells responsive to the priming epitope prevent the relapsing phase of experimental autoimmune encephalomyelitisKeith W Wegmann, H G Archie Bouwer, Cynthia R Gregory, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Neurology and Neuroscience Reports|June 18, 2010
Multiple sclerosis and vitamin D: a review and recommendationsAndrew J Solomon, Ruth H Whitham
Neurology. Clinical Practice|April 23, 2016
Practices of US health insurance companies concerning MS therapies interfere with shared decision-making and harm patientsDennis N Bourdette, Daniel M Hartung, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Ruth H Whitham
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Sharia Ahmed, et al.
Neurology|February 12, 2016
Author responseDaniel M Hartung, Dennis N Bourdette, Sharia Ahmed, et al.
Neurology|April 26, 2015
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?Daniel M Hartung, Dennis N Bourdette, Sharia M Ahmed, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Synthetic Peptide dendrimers block the development and expression of experimental allergic encephalomyelitisKeith W Wegmann, Cynthia R Wagner, Ruth H Whitham, et al.
Journal of Neuroimmunology|July 7, 2014
Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitisKeith W Wegmann, H G Archie Bouwer, Ruth H Whitham, et al.
Journal of Neuroimmunology|April 25, 2013
Targeting T cells responsive to the priming epitope prevent the relapsing phase of experimental autoimmune encephalomyelitisKeith W Wegmann, H G Archie Bouwer, Cynthia R Gregory, et al.
Pageof 2